EGF and breast cancer: Elevated epidermal growth factor (EGF) concentrations might augment proliferation but correlate with gradual breast cancer organoid sinking through basement membrane extract and three-dimensional organization loss, whereas high SB202190 concentrations lead to a profound decrease in organoid establishment efficiency.